治疗选择和Preiser疾病患者的特征
Keisuke Ishizaka1, Koji Moriya1, Takuma Kuroda1
1Department of Orthopaedic Surgery, Niigata Hand Surgery Foundation, Kitakambara, Japan.
Journal of hand surgery global online
|August 21, 2024
概括
普雷泽氏病的治疗因年龄而异. 老年患者通常患有晚期疾病,可能受益于保守的护理或更少的侵入性手术,如关闭辐射骨切除术.
科学领域:
- 整形外科 整形外科 整形外科
- 手术手术手术手术手术
- 放射学 放射学是一门学科.
背景情况:
- 普雷泽病是一种罕见的疾病,影响骨,其病理生理学不清楚,使得诊断和治疗具有挑战性.
- 由于普雷泽病的罕见性,关于最佳治疗策略的数据有限,报告了保守和外科手术的选择.
研究的目的:
- 在普雷塞病中,研究治疗选择与患者特征之间的关系.
- 为了比较与普雷泽病诊断的老年人和非老年人之间的治疗结果和患者因素.
主要方法:
- 对9名被诊断患有普雷泽病的患者进行了回顾性图表审查.
- 患者被分为老年人 (>65岁) 和非老年人组.
- 评估分类 (赫伯特-兰泽塔,沃森,卡拉诺夫),背部间隔段不稳定性 (DISI) 的存在,以及治疗方式.
主要成果:
- 老年患者 (n=5) 更频繁地呈现了先进的赫伯特-兰泽塔阶段和并发性DISI.
- 在老年人群中,保守的治疗是常见的,用于赫伯特-兰泽塔II期病例的关闭辐射骨切除术.
- 非老年患者 (n=4) 一般呈现较早的阶段;治疗包括保守护理和手术干预,如关闭辐射骨切除或血管化骨移植.
结论:
- 患有普雷泽氏病的老年患者在呈现时经常表现出DISI和晚期疾病.
- 对于老年患者,经常采用保守的治疗方法.
- 关闭辐射骨切除术被认为是普雷泽病的不那么侵入性和最佳的外科选择,特别是在老年患者中.
相关概念视频
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
149
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
149